NorthWest Biotherapeutics Inc (NWBO)

[branster]

MartyDG, as of End of September 2024, a little more than half of 15 Million per quarter is Research & Development, rest is Administrative and General Cost.
So once we are getting revenue I figure based on current expenses and if we make 200K per patient we would need about 300 patients only per year to break even, however, a lot can change on expenses and who knows what the pricing structure will look like with NICE. If at a max of 1000 patients per year with no EDEN that puts us at over 100 Million NET after expenses in my calculations.